An interventional study of Needle knife and Corticosteroid: Betamethasone in Trigger Finger, sponsored by Mansoura University Hospital. Active, not recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2025-01-21.
Sponsored by Mansoura University Hospital · Not applicable, Interventional, and Treatment
Trigger finger is a common cause of hand disability and pain in the general population. It is a pathologic condition of the digital pulleys and flexor tendons. Although the pathogenesis is incompletely clear and multifactorial, the most common cause of the trigger finger is the thickened flexor tendon and/or thickened first annular (A1) pulley located at the metacarpophalangeal joint. Currently, ultrasound is considered an effective and valuable tool for assessing the trigger finger, providing static and dynamic evaluations of this condition and a comparison with the adjacent normal digits. Recently, it has been reported that ultrasound-guided percutaneous A1 pulley precise release using a needle knife has received increasing attention in the clinical treatment of trigger fingers and achieved good results. To our knowledge, this is the first clinical study comparing the efficacy and safety of ultrasonic-guided percutaneous A1 pulley release with a needle knife and the ultrasonic-guided steroid injection in treating trigger fingers.
93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.
This study's enrollment of 40 is below the median of 66 across 75 interventional studies indexed under Trigger Finger Disorder.
Browse Trigger Finger Disorder studies →Mansoura University Hospital is the lead sponsor of 50 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Needle knife
Drug: Corticosteroid: Betamethasone
ultrasonography-guided percutaneous A1 pulley release using a needle knife
ultrasonography-guided corticosteroid injection under the A1 pulley
Pain intensity using the visual analog scale (VAS) scoring system
Time frame: Before the procedure as well as after one week, one month, and three months
Functional ability according to the standard quick disabilities of the arm, shoulder, and hand score (Q DASH) questionnaire
Time frame: Before the procedure as well as after one week, one month, and three months
Recurrence: The grade of trigger finger according to Green's classification
Time frame: Before the procedure as well as after one week, one month, and three months
Complications such as inflammation, infection, scarring, wound healing problems, and sensory changes
Time frame: After one week of the procedure
This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Betamethasone
Mansoura University Hospital